Krishnan, Jerry A <br/><br/>
Time to Converge FDA Decisions and Evidence Syntheses for Long-Acting Muscarinic Antagonists and SMART in Guidelines for the Treatment of Asthma.  [electronic resource] 

 -  JAMA  04 2018 
 - 1441-1443 p.  digital 
<br/><br/> Publication Type: Editorial; Comment 
<br/><br/><label>ISSN: </label>1538-3598 
<br/><br/><label>Standard No.: </label>10.1001/jama.2018.2029  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Adrenal Cortex Hormones<br/>Anti-Asthmatic Agents<br/>Asthma<br/>Bronchodilator Agents<br/>Drug Therapy, Combination<br/>Humans<br/>Muscarinic Antagonists<br/>Tiotropium Bromide